Filter
15
Filtered Results: 15
Text search:
van
Ossterhout,
J.
J.
Featured
New Publications
2
Language
Document type
No document type
9
Studies & Reports
5
Guidelines
1
Countries / Regions
Malawi
4
South Africa
2
Thailand
1
Ukraine
1
Uganda
1
Eastern Europe
1
Russia
1
Zambia
1
Authors & Publishers
Publication Years
Category
Studies & Reports
4
HIV & STI
2
Women & Child Health
1
Other
1
Toolboxes
Drug resistance
3
ART Drug Resistance
2
Children & Adolescents
2
Policies & Strategies
1
Childhood TB
1
Treatment & Prevention
1
Vaccines & Immunization
1
South Africa
1
HIV testing & disclosure
1
Eastern Europe
1
HIV
1
Prophylaxis
1
Vaccination
1
Russia
1
General
1
TB/HIV
1
Women
1
Prophylactic Treatment
1
Prevention of mother-to-child transmission (PMTCT)
1
Research & Access
1
PLOS ONE | https://doi.org/10.1371/journal.pone.0217693 June 7, 2019
Цель этого документа – повысить уровень осознания актуальности приоритетных направлений научных исследований по проблеме ТБ/ВИЧ (то есть по тем направлениям, кот...
Journal of the International AIDS Society Vol. 21 (2018) e25133
Many prevention of mother-to-child HIV transmission programmes across Africa initiate HIV-infected (HIV positive) pregnant women on lifelong antiretroviral therapy (ART) on the first day of antenatal care (“same-day” initiation...
Many prevention of mother-to-child HIV transmission programmes across Africa initiate HIV-infected (HIV positive) pregnant women on lifelong antiretroviral therapy (ART) on the first day of antenatal care (“same-day” initiation...
AIDS Research and Therapy 2015, 12:12 (24 April 2015)
Sub-Saharan African Journal of Medicine: Year : 2014 | Volume : 1 | Issue : 1 | Page : 1-14
The study sought to understand the factors that facilitate women to adhere to treatment and return to health facilities for routine care from their own perspective. The researchers focused on Malawi, Uganda and Zambia, early adopters of the global guidance to provide lifelong treatment for pregnant ...
Choko AT et al. Journal of the International AIDS Society 2017, 20:21610 http://www.jiasociety.org/index.php/jias/article/view/21610 | http://dx.doi.org/10.7448/IAS.20.1.21610
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
Avec l’essor des traitements antirétroviraux (TAR) à base de dolutégravir (DTG) pour soigner les personnes vivant avec
le VIH dans le monde, il est important d’estimer la vitesse à laquelle la résistance acquise au DTG apparaît dans les
populations sous TAR. Bien que la résistance au DT...
A medida que el tratamiento antirretrovírico con dolutegravir se extiende a más personas que viven con el VIH en el
mundo, adquiere más importancia estimar la frecuencia con que surge la farmacorresistencia adquirida a este
antirretrovírico en las poblaciones tratadas con esquemas que lo conti...
Dolutegravir HIV drug resistance (HIVDR) data from Africa remain sparse. We reviewed HIVDR results of Malawians on
dolutegravir-based antiretroviral therapy (November 2020– September 2021). Of 6462 eligible clients, 33 samples were submitted to South Africa, 27 were sequenced successfully, and 8 ...
Men are underrepresented in HIV testing services throughout sub-Saharan Africa. HIV testing is critical to achieve the UNAIDS 95-95-95 goals, as it is the first entry point to HIV care. In Malawi, an estimated 14% of HIV positive men are undiagnosed, while only 6% of HIV positive women remain undiag...
